Virtu Financial LLC Orgenesis Inc. Transaction History

Virtu Financial LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$0.39 - $0.63 $4,723 - $7,630	12,112 New	12,112 $7,000
Q2 2022 Aug 09, 2022	SELL	$1.8 - $3.74 $23,562 - $48,956	-13,090 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$2.31 - $3.72 $45,640 - $73,499	-19,758 Reduced 60.15%	13,090 $45,000
Q4 2021 Feb 17, 2022	BUY	$2.61 - $4.9 $85,733 - $160,955	32,848 New	32,848 $95,000
Q4 2020 Feb 24, 2021	SELL	$4.4 - $5.63 $53,020 - $67,841	-12,050 Closed	0 $0
Q3 2020 Dec 11, 2020	BUY	$4.75 - $5.99 $57,237 - $72,179	12,050 New	12,050 $61,000

134K

Ticker ORGS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,545,800
Market Cap $28.1M
Description
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.